Leerink acted as lead book running manager for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FDMT:
- 4D Molecular Therapeutics Reports Positive Interim Trial Results
- 4D Molecular Therapeutics Partners with Otsuka for APAC Market
- 4D Molecular announces 4D-150 license agreement with Otsuka Pharmaceutical
- 4D Molecular Therapeutics Advances in Macular Degeneration Treatment: A Phase 3 Study Update
- 4D Molecular Therapeutics Advances Gene Therapy for Wet AMD
